Gammagard Liquid 10%: Completed Phase III enrollment

Baxter completed enrollment of 390 AD patients ages 50-89 in a double-blind, placebo-controlled, U.S.

Read the full 140 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE